Bengaluru-based Anthem Biosciences' initial public offering (IPO) has been subscribed nearly 10 times on its final day, indicating a 27% listing premium.

The Anthem Biosciences IPO, starting July 14, 2025, aims to raise ₹3,395 crore through an Offer for Sale of 5.96 crore shares by existing shareholders, without proceeds going to the company. Shares ...

Anthem Biosciences is selling its shares in the price band of Rs 540-570, applied for a minimum of 26 shares and its ...

Anthem Biosciences' IPO is seeing huge demand on its last day. The issue has been subscribed 1,400% so far, showing strong interest from all types of investors. At the same time, the GMP has jumped to ...

Anthem Biosciences IPO GMP surged on Wednesday as the Rs 3,395-crore initial share saw robust subscription on the concluding ...

Anthem Biosciences Ltd, a CRDMO founded in 2006, offers end-to-end drug discovery-to-manufacturing services and specialises ...

Check latest subscription status, grey market premium (GMP), allotment date, listing date, and other key details here ...

Anthem Biosciences is raising ₹3,395 crore through an initial share sale, which comprises of entirely an offer-for-sale by ...

Today is the last day for investors to subscribe for the Anthem Biosciences IPO, which so far has gathered a lot of attention ...

The initial public offering of Anthem Biosciences Ltd. has been subscribed to nearly eight times the offer on its third and ...

Anthem Biosciences, ₹3,395 crore IPO was fully subscribed by Day 2, with strong interest from non-institutional investors, ...